[Form 4] Cerence Inc. Insider Trading Activity

Rhea-AI Filing Summary

Cerence Inc. (CRNC) reported an equity award to its Chief Executive Officer and director on a Form 4. On 11/21/2025, the executive acquired 552,766 shares of common stock at a price of $10.35 per share, classified as an acquisition transaction. Following this grant, the executive beneficially owns 1,458,753 shares of Cerence common stock in direct ownership.

The filing notes that this grant represents performance stock units (PSUs) achieved under the company’s FY25 plan, which are scheduled to vest in November 2027. This reflects a performance-based equity incentive aligning the CEO’s compensation with Cerence’s future results over the multi‑year performance period.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Krzanich Brian M

(Last) (First) (Middle)

25 MALL ROAD

SUITE 416

(Street)

BURLINGTON MA 01803

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Cerence Inc. [ CRNC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Executive Officer

3. Date of Earliest Transaction (Month/Day/Year)
11/21/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	11/21/2025		A		552,766(1)	A	$10.35	1,458,753	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. This represents achieved PSUs under the FY25 plan that will vest in November 2027.

Remarks:

	/s/ Jennifer Salinas, Attorney-in-Fact	11/24/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Cerence Inc. (CRNC) disclose in this Form 4 filing?

Cerence Inc. disclosed that its Chief Executive Officer and director acquired 552,766 shares of common stock on 11/21/2025 as part of a performance-based equity award.

Who is the reporting person in the Cerence (CRNC) Form 4 and what is their role?

The reporting person is the company’s Chief Executive Officer, who also serves as a director of Cerence Inc., as indicated in the relationship section.

How many Cerence (CRNC) shares does the CEO beneficially own after this transaction?

After the reported transaction, the CEO beneficially owns 1,458,753 shares of Cerence Inc. common stock in direct ownership.

What is the nature of the 552,766 Cerence (CRNC) shares reported in the Form 4?

The 552,766 shares represent achieved performance stock units (PSUs) under Cerence’s FY25 plan that are scheduled to vest in November 2027.

What transaction code and price are associated with the Cerence (CRNC) CEO’s share acquisition?

The Form 4 lists the transaction as an acquisition (A) of common stock at a price of $10.35 per share on 11/21/2025.

When will the reported Cerence (CRNC) performance stock units vest?

The filing states that the performance stock units associated with this award are expected to vest in November 2027, subject to the terms of the FY25 plan.